Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Trifilieff

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
ONO-6818 Cortech/OnoAlexandre Trifilieff
BMC Pharmacology|April 17, 2004
Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatmentRandolph Corteling, Alexandre Trifilieff
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodelingYasushi Fujitani, Alexandre Trifilieff
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptorAlexandre Trifilieff, John R Fozard
BMC Pharmacology|January 25, 2002
In vivo models of lung neutrophil activation. Comparison of mice and hamstersRandolph Corteling, Daniel Wyss, Alexandre Trifilieff
British Journal of Pharmacology|May 25, 2005
Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammationDaniel Wyss, Olivier Bonneau, Alexandre Trifilieff
International Archives of Allergy and Immunology|April 4, 2003
Involvement of CCR3-reactive chemokines in eosinophil survivalKazuhiko Shinagawa, Alexandre Trifilieff, Gary P Anderson
British Journal of Pharmacology|April 6, 2002
Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammationAlexandre Trifilieff, Christoph Walker, Thomas Keller, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 24, 2003
Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cellsRandolph Corteling, Olivier Bonneau, Stephane Ferretti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activitiesAlexandre Trifilieff, Daniel Wyss, Christoph Walker, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
ONO-6818 Cortech/OnoAlexandre Trifilieff
BMC Pharmacology|April 17, 2004
Gender comparison in a murine model of allergen-driven airway inflammation and the response to budesonide treatmentRandolph Corteling, Alexandre Trifilieff
American Journal of Respiratory and Critical Care Medicine|October 31, 2002
In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodelingYasushi Fujitani, Alexandre Trifilieff
The Journal of Pharmacology and Experimental Therapeutics|May 10, 2012
Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptorAlexandre Trifilieff, John R Fozard
BMC Pharmacology|January 25, 2002
In vivo models of lung neutrophil activation. Comparison of mice and hamstersRandolph Corteling, Daniel Wyss, Alexandre Trifilieff
British Journal of Pharmacology|May 25, 2005
Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammationDaniel Wyss, Olivier Bonneau, Alexandre Trifilieff
International Archives of Allergy and Immunology|April 4, 2003
Involvement of CCR3-reactive chemokines in eosinophil survivalKazuhiko Shinagawa, Alexandre Trifilieff, Gary P Anderson
British Journal of Pharmacology|April 6, 2002
Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammationAlexandre Trifilieff, Christoph Walker, Thomas Keller, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 24, 2003
Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cellsRandolph Corteling, Olivier Bonneau, Stephane Ferretti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activitiesAlexandre Trifilieff, Daniel Wyss, Christoph Walker, et al.
Pageof 4